Latest News

March 13, 2013
The immune system’s T cells, while coordinating responses to diseases and vaccines, act like honey bees sharing information about the best honey sources, according to a new study by scientists at UCSF.
May 21, 2012
A team of researchers from UCSF and UC San Diego has identified an approved arthritis drug that is effective against amoebas in lab and animal studies, suggesting it could offer a low-dose, low cost treatment for the amoebic infections that cause human dysentery throughout the world.
September 19, 2011
Faculty are encouraged to apply for the T1 Translational Catalyst Award, which is designed to help drive promising, early-stage research through the lengthy and complex process of bringing products and procedures to patients.
December 20, 2010
In a recent UCSF-led study in mice, researchers developed a method to stabilize living lung tissue for imaging without disrupting the normal function of the organ. The method allowed the team to observe, for the first time, both the live interaction of living cells in the context of their environment and the unfolding of events in the immune response to lung injury.
December 15, 2010
Brain cancers are deadly more often than not, but UCSF researchers have determined that a particular genetic signature in is associated with longer survival, a discovery that may lead to better therapies for some of the deadliest brain cancers.
October 13, 2010
John Greenspan, a distinguished professor of oral pathology and pathology in the schools of dentistry and medicine, respectively, has been appointed associate dean for Global Oral Health in the UCSF School of Dentistry.
October 04, 2010
Synuclein is a protein that can cause Parkinson’s disease, although it is not clear how. UCSF researcher Robert Edwards, MD, now has discovered that synuclein can affect signal transmission between nerve cells long before disease symptoms arise.
February 24, 2010
Cancer researchers studying the immune system have identified a previously unrecognized set of targets and biomarkers to battle solid tumors.
February 24, 2010
A new discovery about cancer and the immune system points to previously unrecognized targets for drug development to battle solid tumors.